CDKN2A and lung cancer: To analyze whether SIRT7 controls ARF protein stability, we monitored p14ARF protein levels at different time points after treatment with the translation inhibitor cycloheximide (CHX) both in H1299 (Fig. 2A) and in Calu-3 (SI Appendix, Fig. S1E) lung cancer cell lines.